Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Summary
GlobalData’s new report, “Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections” provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to buy
Summary
GlobalData’s new report, “Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections” provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the United Kingdom Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc., Sunovion, B. Braun Melsungen AG and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United Kingdom Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Contents
1 TABLE OF CONTENTS1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION
2.1 What is This Report About?
3 DRUG DELIVERY DEVICES IN UNITED KINGDOM
3.1 Drug Delivery Devices, Market Segmentation
3.2 Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017
3.3 Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2010
3.4 Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2010
3.5 Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017
3.6 Drug Delivery Devices, United Kingdom, Company Share (2009-2010)
4 CENTRAL VENOUS CATHETERS IN UNITED KINGDOM
4.1 Central Venous Catheters, Market Segmentation
4.2 Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2010
4.3 Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2010
4.4 Central Venous Catheters Overall Revenue (2003-2017)
4.5 Central Venous Catheters Overall Volume (2003-2017)
4.6 Central Venous Catheters Average Price (2003-2017)
4.7 Central Venous Catheters Distribution Share (2009-2010)
4.8 Central Venous Catheters, United Kingdom, Company Share (2009-2010)
5 INFUSION SYSTEMS IN UNITED KINGDOM
5.1 Infusion Systems, Market Segmentation
5.2 Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2010
5.3 Infusion Systems Market, United Kingdom, Segment Contribution (%), 2010
5.4 Infusion Systems Overall Revenue (2003-2017)
5.4.1 Syringe Pumps Revenue (2003-2010)
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2010)
5.5 Infusion Systems Overall Volume (2003-2017)
5.5.1 Syringe Pumps Volume (2003-2010)
5.5.2 Ambulatory Infusion Pumps Volume (2003-2010)
5.6 Infusion Systems Average Price (2003-2017)
5.7 Infusion Systems Distribution Share (2009-2010)
5.8 Infusion Systems, United Kingdom, Company Share (2009-2010)
6 METERED DOSE INHALER DEVICES IN UNITED KINGDOM
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017)
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017)
6.3 Metered Dose Inhaler Devices Average Price (2003-2017)
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010)
6.5 Metered Dose Inhaler Devices, United Kingdom, Company Share (2009-2010)
7 NEEDLE FREE INJECTIONS IN UNITED KINGDOM
7.1 Needle Free Injections Overall Revenue (2003-2017)
7.2 Needle Free Injections Overall Volume (2003-2017)
7.3 Needle Free Injections Average Price (2003-2017)
7.4 Needle Free Injections Distribution Share (2009-2010)
7.5 Needle Free Injections, United Kingdom, Company Share (2009-2010)
8 OVERVIEW OF KEY COMPANIES IN UNITED KINGDOM DRUG DELIVERY DEVICES MARKET
8.1 GlaxoSmithKline plc
8.1.1 Company Overview
8.1.2 Share in the United Kingdom Drug Delivery Devices Market
8.2 Boehringer Ingelheim GmbH
8.2.1 Company Overview
8.2.2 Share in the United Kingdom Drug Delivery Devices Market
8.3 AstraZeneca PLC
8.3.1 Company Overview
8.3.2 Share in the United Kingdom Drug Delivery Devices Market
8.4 Baxter International Inc.
8.4.1 Company Overview
8.4.2 Share in the United Kingdom Drug Delivery Devices Market
8.5 Sunovion
8.5.1 Share in the United Kingdom Drug Delivery Devices Market
8.6 B. Braun Melsungen AG
8.6.1 Company Overview
8.6.2 Share in the United Kingdom Drug Delivery Devices Market
8.7 CareFusion Corporation
8.7.1 Company Overview
8.8 Fresenius Kabi AG
8.8.1 Company Overview
8.9 Hospira, Inc.
8.9.1 Company Overview
8.10 Medtronic, Inc.
8.10.1 Company Overview
8.11 Smiths Medical
8.11.1 Company Overview
8.12 Terumo Corporation
8.12.1 Company Overview
8.13 Consort Medical plc
8.13.1 Company Overview
8.14 3M Health Care
8.14.1 Company Overview
8.15 Codman & Shurtleff, Inc.
8.15.1 Company Overview
8.16 JMS CO., LTD.
8.16.1 Company Overview
8.17 Teleflex Incorporated
8.17.1 Company Overview
8.18 Edwards Lifesciences Corporation
8.18.1 Company Overview
8.19 Cook Medical Incorporated
8.19.1 Company Overview
8.20 INJEX - Equidyne Systems
8.20.1 Company Overview
8.21 Bioject Medical Technologies Inc.
8.21.1 Company Overview
8.22 Antares Pharma, Inc.
8.22.1 Company Overview
9 DRUG DELIVERY DEVICES MARKET PIPELINE PRODUCTS
10 FINANCIAL DEALS LANDSCAPE
10.1 Acquisition
10.1.1 Runfold Medical Acquires Zimed
10.2 Partnerships
10.2.1 AorTech International Enters Into Technology License Agreement
11 RECENT DEVELOPMENTS
11.1 Strategy And Business Planning
11.1.1 Aug 19, 2010: Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey
11.1.2 Jul 27, 2010: GE Healthcare Opens New $15 Million Life Sciences Manufacturing Center In Wales, UK
11.1.3 Jul 13, 2010: GE Healthcare Opens New Medical Technology Manufacturing Facility In Cardiff, UK
11.2 Legal and Regulatory
11.2.1 Jan 17, 2011: GlaxoSmithKline Announces Q4 2010 Legal Charge
12 APPENDIX
12.1 Definitions of Markets Covered in the Report
12.1.1 Drug Delivery Devices
12.2 Research Methodology
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panels
12.8 GlobalData Consulting
12.9 Currency Conversion
12.10 Contact Us
12.11 Disclaimer 116
LIST OF TABLES
Table 1: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017
Table 2: Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2010
Table 3: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010
Table 4: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017
Table 5: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017
Table 6: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010
Table 7: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017
Table 8: Drug Delivery Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 9: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2010
Table 10: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010
Table 11: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017
Table 12: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010
Table 13: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017
Table 14: Central Venous Catheters, United Kingdom, Average Price ($), Historic, 2003-2010
Table 15: Central Venous Catheters, United Kingdom, Average Price ($), Forecast, 2010-2017
Table 16: Central Venous Catheters, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 17: Central Venous Catheters, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 18: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2010
Table 19: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010
Table 20: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017
Table 21: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 22: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 23: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 24: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 25: Infusion Systems, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010
Table 26: Infusion Systems, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017
Table 27: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 28: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 29: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 30: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 31: Infusion Systems, United Kingdom, Average Price ($), Historic, 2003-2010
Table 32: Infusion Systems, United Kingdom, Average Price ($), Forecast, 2010-2017
Table 33: Infusion Systems, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 34: Infusion Systems, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 35: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Historic, 2003-2010
Table 36: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Forecast, 2010-2017
Table 37: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Historic, 2003-2010
Table 38: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Forecast, 2010-2017
Table 39: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Historic, 2003-2010
Table 40: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Forecast, 2010-2017
Table 41: Metered Dose Inhaler Devices, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 42: Metered Dose Inhaler Devices, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 43: Needle Free Injections, United Kingdom, Revenue ($m) Historic, 2003-2010
Table 44: Needle Free Injections, United Kingdom, Revenue ($m) Forecast, 2010-2017
Table 45: Needle Free Injections, United Kingdom, Volume (Units) Historic, 2003-2010
Table 46: Needle Free Injections, United Kingdom, Volume (Units) Forecast, 2010-2017
Table 47: Needle Free Injections, United Kingdom, Average Price ($), Historic, 2003-2010
Table 48: Needle Free Injections, United Kingdom, Average Price ($), Forecast, 2010-2017
Table 49: Needle Free Injections, United Kingdom, Distribution Share by Revenue ($m), 2009-2010
Table 50: Needle Free Injections, United Kingdom, Company Share by Revenue ($m), 2009-2010
Table 51: Drug Delivery Devices Market Pipeline Products
Table 52: Runfold Medical Acquires Zimed
Table 53: AorTech International Enters Into Technology License Agreement
Table 54: USD to Local Currency, United Kingdom, Average Actual Rate 2003-2010 115
LIST OF FIGURES
Figure 1: Drug Delivery Devices, Market Segmentation
Figure 2: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), 2003-2017
Figure 3: Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2010
Figure 4: Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2010
Figure 5: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Historic, 2003-2010
Figure 6: Drug Delivery Devices, United Kingdom, Overall Revenue ($m), Forecast, 2010-2017
Figure 7: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2003-2017
Figure 8: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010
Figure 9: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017
Figure 10: Drug Delivery Devices, United Kingdom, Company Share (%), 2010
Figure 11: Central Venous Catheters, Market Segmentation
Figure 12: Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2010
Figure 13: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2010
Figure 14: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010
Figure 15: Central Venous Catheters, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 16: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010
Figure 17: Central Venous Catheters, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017
Figure 18: Central Venous Catheters, United Kingdom, Company Share (%), 2010
Figure 19: Infusion Systems, Market Segmentation
Figure 20: Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2010
Figure 21: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2010
Figure 22: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Historic, 2003-2010
Figure 23: Infusion Systems, United Kingdom, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 24: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 25: Syringe Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 26: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 27: Ambulatory Infusion Pumps, United Kingdom, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 28: Infusion Systems, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010
Figure 29: Infusion Systems, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017
Figure 30: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 31: Syringe Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 32: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 33: Ambulatory Infusion Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 34: Infusion Systems, United Kingdom, Company Share (%), 2010
Figure 35: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Historic, 2003-2010
Figure 36: Metered Dose Inhaler Devices, United Kingdom, Revenue ($m) Forecast, 2010-2017
Figure 37: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Historic, 2003-2010
Figure 38: Metered Dose Inhaler Devices, United Kingdom, Volume (Units) Forecast, 2010-2017
Figure 39: Metered Dose Inhaler Devices, United Kingdom, Company Share (%), 2010
Figure 40: Needle Free Injections, United Kingdom, Revenue ($m) Historic, 2003-2010
Figure 41: Needle Free Injections, United Kingdom, Revenue ($m) Forecast, 2010-2017
Figure 42: Needle Free Injections, United Kingdom, Volume (Units) Historic, 2003-2010
Figure 43: Needle Free Injections, United Kingdom, Volume (Units) Forecast, 2010-2017
Figure 44: Needle Free Injections, United Kingdom, Company Share (%), 2010
Figure 45: GlaxoSmithKline plc, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010
Figure 46: Boehringer Ingelheim GmbH, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010
Figure 47: AstraZeneca PLC, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010
Figure 48: Baxter International Inc., Company Share (%),United Kingdom Drug Delivery Devices Market, 2010
Figure 49: Sunovion, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010
Figure 50: B. Braun Melsungen AG, Company Share (%),United Kingdom Drug Delivery Devices Market, 2010 93
COMPANIES MENTIONED
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca PLC
Baxter International Inc.
Sunovion
B. Braun Melsungen AG
CareFusion Corporation
Fresenius Kabi AG
Hospira, Inc.
Medtronic, Inc.
Smiths Medical
Terumo Corporation
Consort Medical plc
3M Health Care
Codman & Shurtleff, Inc.
JMS CO., LTD.
Teleflex Incorporated
Edwards Lifesciences Corporation
Cook Medical Incorporated
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
Antares Pharma, Inc. Skip to top